Episode #55 - Epilepsy Drug Development: Clinical Trials featuring Dr. Kelly Knupp

Share
Subscribe

The multi-step process of developing a new epilepsy drug can take many years and requires a small army of researchers, chemists, scientists, physicians, and data analysts. But ultimately it’s the human volunteers and their responses to the drug that will determine if a new medication wins FDA approval. Clinical trials are the first time that the drug being evaluated is given to human volunteers. They are conducted in multiple phases and focus on safety, effectiveness, and potential side effects. Each phase of the clinical trial is carefully designed and rigorously regulated by the FDA to ensure the well-being of the volunteers and the collection of unbiased data by researchers. It’s a thoughtful and thorough process that holds the promise of transforming the lives of those with epilepsy.

In the second part of our 4-part series exploring the drug development process and clinical trial participation, we speak with Dr. Kelly Knupp, Associate Research Director of the Neuroscience Institute and Director of the Dravet Program at Children’s Hospital Colorado. Dr. Knupp provides a comprehensive explanation of human clinical trials in layman’s terms. She details the procedures and goals of each phase of the process, explains trial terminology, outlines key personnel and responsibilities, and describes the FDA requirements for new drug approval. It’s everything you want to know about clinical trials but didn’t know how to ask.

Download Audio

Want to download this episode? Fill out the form below and enjoy the podcast any time you’d like!

    Back to Episode Download PDF

    Epilepsy Drug Development: Clinical Trials - Transcript

    Related Episodes

    featured episode
    Infantile SpasmsResearch
    November 29, 2023

    #130 Infantile Spasms: The Facts, The Research, and The Hope for the Future

    Guest: Dr. Chris Dulla

    This week on Seizing Life® epilepsy researcher Dr. Chris Dulla provides information about infantile spasms, from detection and diagnosis to current research and future improvements in treatment.

    featured episode
    SUDEPResearch
    October 18, 2023

    #127 Searching for Answers, Providing Support, and Understanding Grief After the Death of a Child

    Guest: Dr. Richard Goldstein

    This week on Seizing Life® Dr. Richard Goldstein, Associate Professor of Pediatrics at Harvard Medical School, discusses his research into both Sudden Unexpected Death in Pediatrics (SUDP) and the grieving process of bereaved parents.

    featured episode
    AdvocacyResearch
    May 31, 2023

    #117 Epilepsy Researcher Compounds Lab Work with Fundraising

    Guest: Dr. Patrice Jackson-Ayotunde

    This week on Seizing Life® Dr. Patrice Jackson-Ayotunde discusses her 20+ years of epilepsy drug research and her decade-long epilepsy fundraising efforts.